Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation

Journal of Experimental Zoology Part A: Comparative Experimental Biology

Volumn 305, Issue 5, 2006, Pages 420-427

  Bagis, Haydar ^a,d   Arat, Sezen ^a   Mercan, Hande Odaman ^a   Aktoprakligil, Digdem ^b   Caner, Muge ^b   Turanli, Eda Tahir ^a,c   Baysal, Kemal ^a   Turgut, Gazi ^a   Sekmen, Sakir ^a   Cirakoglu, Beyazit ^a,b  

^a Research Institute for Genetic Engineering and Biotechnology   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^d SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS RNA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE TRANSMISSION; DNA REPLICATION; GENE EXPRESSION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; LIVER; LIVER CELL; METABOLISM; MICROINJECTION; MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIROLOGY; VIRUS GENOME;

ANIMALS; DISEASE TRANSMISSION, VERTICAL; DNA REPLICATION; DNA, VIRAL; GENE EXPRESSION; GENOME, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROINJECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANS-ACTIVATORS;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 33646502625     PISSN: 15488969     EISSN: 1552499X     Source Type: Journal    
DOI: 10.1002/jez.a.277     Document Type: Article

References (32)

1. Araki K, Miyazaki JI, Hino, et al. 1989. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl acad Sci 86:207-211.
2. Babinet C, Forza H, Morello D, et al. 1985. Specific expression of hepatitis B surface antigen in transgenic mice. Science 230:1160-1163.
3. Bagis H, Papuccuoglu S. 1997. Studies on the production of transgenic mice. Turk J Vet Anim Sci 21:287-292.
4. Bagis H, Odaman H, Sagirkaya H, Dinnyés A. 2002a. Production of transgenic mice from vitrified pronuclear-stage embryos. Mol Reprod Dev 61:173-179.
5. Bagis H, Keskintepe L, Odaman H, Sagirkaya H. 2002b. Comparing the birth rates of microinjected hybrid mouse zygotes transferred into outbred and foster mothers. Turk J Vet Anim Sci 26:329-333.
6. Bagis H, Odaman Mercan H., Dinyéss A. 2004. Exposure to warmer post-operative temperatures reduces hypothermia caused by anaesthesia and significantly increases the implantion rate of transferred embryos in mouse. Lab Anim 38:50-54.
7. Bilet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V. 1995. In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol 69:5912-5916.
8. Chisari FV. 1995. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 22:1316-1325.
9. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
10. Chisari FV, Pinkert CA, Mulich DR, Fillipi P, McLachlan A, Palmiter RD, Brinster RL. 1985. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230:1160-1163.
11. Dae-Yeul Yu, Hyung-Bae M, Jin-Kyong S, Sangkyun J, Seong-Lan Y, Heesik Y, Yong-Mahn H, Chul S, Jung-Sun P, Chul-ho L, et al. 1991. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31:123-132.
12. Davis HL, Brazolot Millan CL, Mancini M. 1997. DNA-based immunization against hepatitis B surface antigen (HbsAg) in normal and HbsAg-transgenic mice. Vaccine 15:849-852.
13. Dragani TA, Mancini G, Farza H. 1989. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen induced hepatocarcinogenesis. Carcinogenesis 11:9953-9956.
14. Drinkwater NR. 1989. Genetic control of hepatocarcinogenesis in inbred mice. In: Colburn NH, editors. Genes and signal transduction in multistage carcinogenesis. New York: Marcel Dekker Inc. p 3-17.
15. Farza H, Hadchouel M, Scotto. 1988. Replication and gene expression of hepatitis B virus in a trasngenic mouse that contains the complete viral genome. J Virol 62:4144-4152.
16. Guidotti LG, Martinez YT, Loh CE, Rogler, Chisari FV. 1994. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J Virol 68:5469-5475.
17. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. High-level hepatitis B virus replication in transgenic mice. J Virol 69:6158-6169.
18. Hogan B, Beddigton R, Costantini F, Lacy E. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 494p.
19. Kim CM, Koike K, Saito T, Miyamura, Dey G. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320.
20. Koike K. 1999. Transgenic mouse models of viral hepatitis: insight into viral hepatocarcinogenesis. Viral Hep Rev 5:177-203.
21. Koike K, Moriya K, Lino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. 1994. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819.
22. Konkel DA, Tilghman SM, Leder P. 1978. The sequence of the chromosomal mouse beta-globin major gene: homologies in capping, splicing and poly(A) sites. Cell 15:1125-1132.
23. Lee T-H, Finegold MJ, Shen RF, DeMayo JL, Woo SLC, Butel JS. 1990. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64:5939-5947.
24. Lun-Gen L, Min-De Z, Yi-Min M, Jing-Yuan F, Yu-Lin S, Zhao-Hui S, Ai-Ping C. 2004. Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice. World J Gastroenterol 10:1176-1179.
25. McLachlan A, Millich DR, Raney AK, Kegs MG, Hughes JL, Soreg J, Chisari FV. 1987. Expression of hepatitis B virus surface and core antigens: influences of pre-Sand precoresequnces. J Virol 61:683-692.
26. Perfumo S, Amicone L, Colloca S, Giorgio M, Pozzi L, Tripodi M. 1992. Recognition efficieny of the hepatitis B virus polyadenylation signal is tissue in transgenic mice. J Virol 66:6819-6823.
27. Peters M, Vierling J, Gershwin ME, Millich D, Chisari FV, Hoofnagle JH. 1991. Immunology and the liver. Hepatology 13:977-994.
28. Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spinder G, Kock J, et al. 1997. Long-term expression of the hepatitis B virus core-e- and X proteins does not cause pathologic changes in transgenic mice. J Hepatol 26:119-130.
29. Sambrook J, Frish EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
30. Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. 1986. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37-47.
31. Wollersheim M, Debelka U, Hofschneider PH. 1988. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545-552.
32. Yaginuma K, Yshirakata Y, Kobayashi M, Koike K. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci 84:2678-2682.